Relmex blood glucose testing system
Taiwan·Risk Class 2·Aksotek Company·Registered Mar 24, 2021 – Mar 24, 2026Expired- Analysis ID
- 404f8b4cca7640dd1d94b7c9dbeaa3a3
- Manufacturer
- Aksotek Company
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Aksotek Company
- Intended Use
- It is suitable for in vitro diagnostic use, as a monitoring of blood sugar, it can provide diabetic patients to self-detect fingertip microvascular blood glucose value, or provide professionals to detect venous or arterial whole blood and neonatal microvascular blood glucose value.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
- Registration Date
- Mar 24, 2021
- Expiry Date
- Mar 24, 2026
Top companies providing products similar to "Relmex blood glucose testing system"
Recently registered similar products
Access comprehensive regulatory information for Relmex blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 404f8b4cca7640dd1d94b7c9dbeaa3a3 and manufactured by Aksotek Company. The authorized representative in Taiwan is Aksotek Company.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Aksotek Company, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.